Locations
Seattle, WA, USA · University of Washington, Seattle, WA, USA
industry
Biotechnology · DeepTech · Food · Health · Software
Size
11-50 employees
Stage
Series B
founded in
2014
Cyrus Biotechnology is an AI-driven discovery company that focuses on naturally existing proteins to develop superior therapeutics through AI and deep mutagenesis. With over 30 discovery programs in collaboration with major partners, Cyrus employs a proven platform that integrates novel algorithms and sophisticated laboratory methods. Their lead programs target severe autoimmune diseases and therapeutic immuno-cytokines, addressing a significant clinical market. The company has established a strong market position by leveraging its innovative protein design capabilities and collaborations with top-tier biotech firms.
Something looks off?